Literature DB >> 20202483

Crohn's disease is a risk factor for preterm birth.

Olof Stephansson1, Heidi Larsson, Lars Pedersen, Helle Kieler, Fredrik Granath, Jonas F Ludvigsson, Henrik Falconer, Anders Ekbom, Henrik Toft Sørensen, Mette Nørgaard.   

Abstract

BACKGROUND & AIMS: Women with Crohn's disease (CD) are considered to be at increased risk for adverse outcomes of pregnancy. However, the few studies assessing this risk have had small sample sizes and limitations. We examined outcomes of pregnancy among a large cohort of primiparous women with CD.
METHODS: Our population-based prevalence study utilized data from medical birth registries in Sweden and Denmark between 1994 and 2006. Linking birth registry data with national patient registries, we identified 2377 women with a hospital diagnosis of CD prior to delivery and 869,202 women with no diagnosis of CD. Using logistic regression analysis, we estimated relative risks with 95% confidence intervals (CI) for pre-eclampsia, preterm birth, 5-minute Apgar scores below 7, cesarean section, small for gestational age (SGA), stillbirth, and congenital malformations.
RESULTS: Maternal CD was associated with increased risk of moderately and very preterm birth (prevalence odds ratio [POR], 1.76; 95% CI, 1.51-2.05; and POR, 1.86; 95% CI, 1.38-2.52, respectively). Maternal CD was also associated with increased risk for cesarean section (POR, 1.93; 95% CI, 1.76-2.12). The strongest associations with CD were observed for prelabor cesarean section and induced preterm delivery. Risk of small size for gestational age birth was slightly increased among women with CD, especially during the time period of 2002-2006 (POR, 1.43; 95% CI, 1.09-1.89). We found no increased risks for pre-eclampsia, low 5-minute Apgar score, stillbirth, or congenital malformations.
CONCLUSIONS: Maternal CD is a risk factor for preterm birth, but not birth defects. Copyright 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20202483     DOI: 10.1016/j.cgh.2010.02.014

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  28 in total

Review 1.  Reproductive Planning and Contraception for Women with Inflammatory Bowel Diseases.

Authors:  Lori M Gawron; Jessica Sanders; Katelyn P Steele; Ann D Flynn
Journal:  Inflamm Bowel Dis       Date:  2016-02       Impact factor: 5.325

2.  Inadequate Gestational Weight Gain Predicts Adverse Pregnancy Outcomes in Mothers with Inflammatory Bowel Disease: Results from a Prospective US Pregnancy Cohort.

Authors:  May-Bente Bengtson; Christopher F Martin; Geir Aamodt; Morten H Vatn; Uma Mahadevan
Journal:  Dig Dis Sci       Date:  2017-03-22       Impact factor: 3.199

3.  Dietary Patterns in women with Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes: Results from The Norwegian Mother and Child Cohort Study (MoBa).

Authors:  Thea Myklebust-Hansen; Geir Aamodt; Margaretha Haugen; Anne Lise Brantsæter; Morten H Vatn; May-Bente Bengtson
Journal:  Inflamm Bowel Dis       Date:  2017-12-19       Impact factor: 5.325

4.  Oral corticosteroid use during pregnancy and risk of preterm birth.

Authors:  Kristin Palmsten; Gretchen Bandoli; Gabriela Vazquez-Benitez; Min Xi; Diana L Johnson; Ronghui Xu; Christina D Chambers
Journal:  Rheumatology (Oxford)       Date:  2020-06-01       Impact factor: 7.580

5.  First-in-Human Case Study: Pregnancy in Women With Crohn's Perianal Fistula Treated With Adipose-Derived Stem Cells: A Safety Study.

Authors:  Raquel Sanz-Baro; Mariano García-Arranz; Hector Guadalajara; Paloma de la Quintana; Maria Dolores Herreros; Damián García-Olmo
Journal:  Stem Cells Transl Med       Date:  2015-04-29       Impact factor: 6.940

6.  Obstetric and neonatal complications among women with autoimmune disease.

Authors:  Andrew Williams; Katherine Grantz; Indulaxmi Seeni; Candace Robledo; Shanshan Li; Marion Ouidir; Carrie Nobles; Pauline Mendola
Journal:  J Autoimmun       Date:  2019-05-27       Impact factor: 7.094

Review 7.  Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease.

Authors:  Wendy A Goodman; Ian P Erkkila; Theresa T Pizarro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-09-08       Impact factor: 46.802

Review 8.  Inflammatory Bowel Disease Increases Risk of Adverse Pregnancy Outcomes: A Meta-Analysis.

Authors:  Aoibhlinn O'Toole; Ogochukwu Nwanne; Tracy Tomlinson
Journal:  Dig Dis Sci       Date:  2015-06-13       Impact factor: 3.199

9.  Contraceptive method selection by women with inflammatory bowel diseases: a cross-sectional survey.

Authors:  Lori M Gawron; Andrew J Gawron; Amanda Kasper; Cassing Hammond; Laurie Keefer
Journal:  Contraception       Date:  2014-01-07       Impact factor: 3.375

10.  Pregnancy and Inflammatory Bowel Disease.

Authors:  Jana G Hashash; Sunanda Kane
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.